Emil D. Kakkis

2015

In 2015, Emil D. Kakkis earned a total compensation of $5.4M as President and Chief Executive Officer at Ultragenyx Pharmaceutical, a 673% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$280,875
Option Awards$3,578,620
Salary$535,000
Stock Awards$967,746
Other$38,419
Total$5,400,660

Kakkis received $3.6M in option awards, accounting for 66% of the total pay in 2015.

Kakkis also received $280.9K in non-equity incentive plan, $535K in salary, $967.7K in stock awards and $38.4K in other compensation.

Rankings

In 2015, Emil D. Kakkis' compensation ranked 1,445th out of 13,638 executives tracked by ExecPay. In other words, Kakkis earned more than 89.4% of executives.

ClassificationRankingPercentile
All
1,445
out of 13,638
89th
Division
Manufacturing
509
out of 5,190
90th
Major group
Chemicals And Allied Products
188
out of 1,854
90th
Industry group
Drugs
145
out of 1,528
91st
Industry
Pharmaceutical Preparations
119
out of 1,182
90th
Source: SEC filing on April 28, 2017.

Kakkis' colleagues

We found five more compensation records of executives who worked with Emil D. Kakkis at Ultragenyx Pharmaceutical in 2015.

2015

John Pinion

Ultragenyx Pharmaceutical

Chief Quality Operations Officer and Executive Vice President Analytical Sciences and Research

2015

Jayson Dallas

Ultragenyx Pharmaceutical

Chief Commercial Officer and Executive Vice President

2015

Dennis Huang

Ultragenyx Pharmaceutical

Chief Technical Operations Officer and Senior Vice President

2015

Shalini Sharp

Ultragenyx Pharmaceutical

Chief Financial Officer

2015

Thomas Kassberg

Ultragenyx Pharmaceutical

Chief Business Officers and Executive Vice President

News

In-depth

You may also like